Aging Immunity, Rising Stakes: The Adjuvant Advantage in Influenza Prevention

Overview

• Understand the burden of influenza in the United States (US) and the continued decline in influenza vaccination coverage, particularly among adults aged 65 years and older
• Discuss and explore advancements in influenza vaccine technology
• Explore the potential benefits of adjuvanted influenza vaccines over standard-dose for older adults
• Focus on the insights provided by real-world evidence (RWE) regarding vaccine effectiveness and its impact on patient care